Stephens Investment Management Group LLC raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 8.9% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 179,716 shares of the company's stock after buying an additional 14,631 shares during the period. Stephens Investment Management Group LLC owned about 0.14% of Henry Schein worth $13,101,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock worth $26,000 after buying an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein in the 2nd quarter worth approximately $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein in the 2nd quarter worth approximately $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock worth $109,000 after purchasing an additional 1,100 shares during the period. 96.62% of the stock is currently owned by institutional investors.
A number of research firms recently commented on HSIC. JPMorgan Chase & Co. decreased their price objective on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research note on Monday, August 12th. StockNews.com lowered shares of Henry Schein from a "hold" rating to a "sell" rating in a research note on Wednesday. Robert W. Baird lowered their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a report on Wednesday, August 7th. Barrington Research restated an "outperform" rating and set a $82.00 price target on shares of Henry Schein in a report on Friday, September 20th. Finally, Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Two research analysts have rated the stock with a sell rating, five have given a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $77.50.
View Our Latest Report on HSIC
HSIC stock opened at $70.37 on Friday. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The company has a fifty day simple moving average of $70.64 and a 200 day simple moving average of $69.79. The firm has a market cap of $8.92 billion, a PE ratio of 26.06, a PEG ratio of 2.03 and a beta of 0.86.
Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. Henry Schein's quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.31 EPS. Sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.14% of the company's stock.
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.